Current Vascular Pharmacology

译名:当代血管药理学

SCIEJCR Q3中科院4区

1-3

2026

影响因子区间

平台估算

投稿周期

26%

2025

中国作者发文占比

1800 EUR

费用说明

收费

期刊简介:Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

【译文】Current Vascular Pharmacology 发表基于临床和研究的基础综述/迷你综述、原创研究文章、信件、辩论、药物临床试验研究和特邀编辑问题,以更新所有关注血管疾病治疗的人士,架起临床实践和持续研究之间的桥梁。血管疾病是西方国家最常见的死亡原因,其在发展中国家的发病率也在增加。因此,大量研究致力于建立有效的急性血管事件治疗方法。长期治疗也受到了相当多的关注(例如,症状缓解)。此外,有效的预防,无论是初级还是二级预防,都得到了几个里程碑式试验的发现的支持。血管疾病是一个复杂的领域,涉及初级保健医生、护士执业医师以及多个专业,包括心脏病学、血管和心胸外科、普通医学、放射学、临床药理学和神经学(中风单元)。

出版社
Bentham Science Publishers
语言
English
学科
医学
ISSN
1570-1611
eISSN
1875-6212
出版频率
季刊
创刊年份
2003
投稿网址
http://benthamscience.com/journal/authors-guidelines.php?journalID=cvp#top
最近更新
2026-04-02 18:16:40
Current Vascular Pharmacology

指标当前值近三年趋势
JCR分区Q3
暂无
中科院分区4区
暂无
影响因子区间1-3
暂无